This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Yet, missing from these debates was one critical topic: the future of medical cannabis and protections for patients. As we head toward the 2024 election, it’s clear that cannabis policies will shift in the next Congress, impacting the lives of patients and families across the nation.
With a proven track record of driving significant legislative change, Crista Eggers successfully spearheaded statewide ballot initiatives in 2022 and 2024, culminating in a landmark victory for voter-approved legalization in November 2024.
A letter from ASA Founder & President The positive impacts of medical cannabis on patients and the healthcare systems that serve them are profound and far-reaching. Today, cannabis-based therapies provide relief to over 6 million Americans registered in medical cannabis programs in 38 states, D.C., and four of the five U.S.
What's Inside For September 2024: DEA Hearing Delay on Cannabis Rescheduling Patients caught in the middle of CA Hemp Product Ban ASA releases What’s in Your Cannabis? A Patient & Consumer Guide to Navigating Cannabis Safety. Learn More about ASA Member Benefits & Join Today!
For Immediate Release: August 28, 2024 Washington, D.C. — In light of the Drug Enforcement Administration’s (DEA) announcement to schedule a hearing on the rescheduling of cannabis, Americans for Safe Access (ASA) emphasizes the urgent need for compassionate leadership in Congress to advocate for the rights of medical cannabis patients.
Americans for Safe Access launched the Compassionate Candidate Campaign to provide candidates in the 468 Congressional races in the 2024 Election information on policies that will improve the lives of medical cannabis patients. A Patient & Consumer Guide to Navigating Cannabis Safety.
Illinois officials recently released the Annual Cannabis Report for Fiscal Year 2024. The focus of the subsequent three meetings was the examination of conditions under consideration for addition to the list of debilitating conditions that are qualifying for participation in the Medical Cannabis Patient Program (MCPP).
For Immediate Release: September 5, 2024 AMID RECENT CANNABIS RECALLS, AMERICANS FOR SAFE ACCESS RELEASES CRITICAL REPORT: "What’s in Your Cannabis? A Patient & Consumer Guide to Navigating Cannabis Safety" Washington, D.C. A Patient & Consumer Guide to Navigating Cannabis Safety.
Michigan’s cannabis landscape is teeming with innovation and quality, spanning a diverse range of products that satisfy both recreational enthusiasts and medical patients alike.
On September 26th, medical cannabis advocates from Hawaii to Florida gathered on Capitol Hill for the Validated Voices Summit, representing patients from across the nation.
This cozy city is home to 20 dispensaries that cater to both adult-use consumers and medical patients, with the range and quality control cannabis lovers have come to expect […] The post The best-rated weed dispensaries in Fort Collins for 2024 appeared first on Leafly.
December 2022, I published a 6-part series titled, “What Illinois cannabis patients really want” to start a dialogue about the large gap between patients’ needs, wishes, concerns, and recommendation for improving the Medical Cannabis Patient Program (MCPP) and the actual amendments to the law legislators have introduced.
Illinois officials recently released the Annual Cannabis Report for Fiscal Year 2024. IDFPR FY2025 goals include: Continue working with CROO and the legislature to pass legislation to expand access to cannabis for medical patients. Implement the comprehensive rules under the CRTA filed in August of 2024.
For 2024, we have added more advertising options, new services, and updated our logos and website. The continuous feedback, concerns, and questions received from Illinois cannabis insiders keeps our finger on the pulse of the industry, consumer interests, latest data, latest trends, and medical patients needs.
Now, pro-cannabis groups have their sights set on 2024. . There are two years still to go until the 2024 ballot takes place. Rather, the avid cannabis supporter stated that a January 2023 deadline would be more feasible to ensure that Wyoming’s legalization initiatives face a fair vote at the 2024 ballot.
That sought to expand patient access to the drug. The decision, announced on October 21, 2024, has sparked widespread debate, leaving advocates for cannabis reform disappointed. Arkansas Supreme Court Blocks Medical Marijuana Ballot Measure. Read More
A medical patient could end up in jail for possessing even small amounts of marijuana. Currently, with t he required certificate from a certified medical practitioner due to a qualifying condition, medical marijuana possession for patients is allowed in South Dakota. Patients cannot cultivate without explicit authorization.
The Decline of Medical Marijuana in Massachusetts: What It Means for Patients In recent years, Massachusetts, once a pioneer in cannabis reform, has seen its medical marijuana program gradually overshadowed by the booming recreational market. Let’s explore how this shift occurred and its implications for patients.
Playing Defense in the 119th Congress The 2024 Elections shook up leadership in the administration and in Congress, putting a cohort of anti-cannabis representatives in positions that could significantly impact gains to patient access from medical cannabis programs and hemp markets.
For 2024, retail sales by licensed medical cannabis dispensaries finished at $285,059,601.92. The 2024 totals continued a 3-year downward trend for yearly totals, dropping below $300 million for the first time since 2019. The 2024 totals dropped nearly $40 millions from the 2023 totals of $324,792,664.73. February: $24,427,904.62
No data exists on how many registered medical patients are actively growing cannabis in Illinois. Though many reasons factor into the number of patients who grow and why, two trendlines that are heading in opposite direction may suggest more medical cannabis patients in Illinois are opting to grow their own medicine.
For immediate release: Media Briefing on the Next Steps of the Rescheduling Process July 22, 2024, 1 pm ET Zoom Conference: Please go to the bottom of this page for the Zoom sign-in link.
Licensed medical cannabis dispensaries served 60,401 unique patients, who purchased 1,265,482 grams of dry cannabis. Total retail sales for 2024 reached $147,266,853.89. Monthly Totals for 2024: January: $24,338,551.30 In June, Illinois dispensaries sold $11,112,600.33 in dry flower sales and $11,993,326.62 March: $25,917,010.11
We will be discussing the state of the medical cannabis in Illinois and what effective strategies we can use to deal with some of the issues medical cannabis patients are having,” said Chicago NORML Executive Director Arianne Richards. The meeting is set for Jan. 7, from at 2 p.m.-3:30 3:30 p.m. “We
"This is a setback for the growth and improvement of our existing program, but it will not be the last attempt to ease the barriers Arkansas’s medical patients encounter." The post Arkansas: Supreme Court Rules Against Medical Marijuana Ballot Measure appeared first on NORML.
Cannabis Helps Cancer Patients Ditch Opiates, Study Finds. The patients came from 34 states that had not legalized medical cannabis by Jan. The study tracked the patients’ opiate use, seeing how it changed as some of the 34 states legalized medical cannabis over the five-year span. Let’s dive into this week’s cannanews.
Licensed medical cannabis dispensaries served 62,864 unique patients, who purchased 1,360,599 grams of dry cannabis. Total retail sales for 2024 reached $99,749,327.83. Monthly Totals for 2024: January: $24,338,551.30 In April, Illinois dispensaries sold $11,853,546.55 in dry flower sales and $13,213,427.59 March: $25,917,010.11
NECANN has announced its program schedule for the 2024 Illinois Cannabis Convention. The 2024 Illinois Cannabis Convention programing contributors include The 1937 Group , Illinois Women in Cannabis , Smart Cannabis , and others. The 4 th annual convention, set for 10 a.m-3 Stop by booth 221 and say hi to the Illinois News Joint team.
Licensed medical cannabis dispensaries served 58,577 unique patients, who purchased 1,221,636 grams of dry cannabis. Total retail sales for 2024 reached $215,829,673.13. Monthly Totals for 2024: January: $24,338,551.30 In September, Illinois dispensaries sold $10,516,825.48 in dry flower sales and $11,182,563.32
Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. It would not allow patients to smoke herbal marijuana or vape, but would allow forms including pills, oils, lozenges and patches.
If passed, vaporizable dried raw cannabis would be included with the products available to Iowas medical patients. Companies & Iowa Patients Are Hopeful For Change Lucas Nelson, president of MedPharm Iowa, owns and operates Bud & Marys Cannabis in the state. Theres a patient who visits us from just outside of Ottumwa.
Only June 2024 (the previous month) medical cannabis sales totals of $23,105,926.95 Licensed medical cannabis dispensaries served 61,066 unique patients, who purchased 1,294,650 grams of dry cannabis. Total retail sales for 2024 reached $170,617,973.63. Monthly Totals for 2024: January: $24,338,551.30 were lower.
November totals jumped up to $23,534,153.65, the highest monthly totals since May 2024. Licensed medical cannabis dispensaries served 59,467 unique patients, who purchased 1,322,044 grams of dry cannabis. Monthly Totals for 2024: January: $24,338,551.30 Retail sales of medical cannabis for November included $11,217,284.40
Licensed medical cannabis dispensaries served 62,518 unique patients, who purchased 1,343,762 grams of dry cannabis. Total retail sales for 2024 reached $74,682,676.11. Monthly Totals for 2024: January: $24,338,551.30 In March, Illinois dispensaries sold $12,245,278.55 in dry flower sales and $13,671,731.56 March: $25,917,010.11
Licensed medical cannabis dispensaries served 60,593 unique patients, who purchased 1,323,604 grams of dry cannabis. Total retail sales for 2024 reached $194,130,227.26. Monthly Totals for 2024: January: $24,338,551.30 In August, Illinois dispensaries sold $11,332,050.49 in dry flower sales and $12,180,708.64 March: $25,917,010.11
Florida-based cannabis giant Trulieve recently doubled its contribution to the Smart & Safe Florida political committee with another $5 million toward a 2024 ballot initiative to legalize adult-use cannabis. 1, 2024, with election officials needing 30 days to check signatures before that deadline. 23 to circulate the petition.
Licensed medical cannabis dispensaries served 60,179 unique patients, who purchased 1,251,318 grams of dry cannabis. Licensed medical cannabis dispensaries served 60,906 unique patients, who purchased 1,243,042 grams of dry cannabis. Total retail sales for 2024 reached $48,765,439.01. in dry flower sales and $12,953,299.44
WLOS) — On April 20, 2024, hundreds of people with medical cannabis patient cards lined up to buy the first legal medical marijuana within North Carolina and the nation where it remains illegal. CHEROKEE, N.C. It’s raising safety questions among members of the Eastern Band of Cherokee Indians, as well. Read More
– February 29, 2024) – The Stock Day Podcast welcomed StrainsForPains, Inc. OTC Pink: EBYH) (“the Company”), a medical marijuana recommendation engine that guides patients to the appropriate cannabinoid levels, medical cannabis strains, and consumption methods for their specific ailment.
Last week, Illinois officials released the Annual Cannabis Report for Fiscal Year 2024. In coordination with the Cannabis Regulation Oversight Office (CROO) and legislators, IDFPR has begun efforts to allow medical patients to receive their medical tax rate at any dispensary in Illinois. In addition, IDFPR lists as its No.
Licensed medical cannabis dispensaries served 58,928 unique patients, who purchased 1,265,151 grams of dry cannabis. Total 2024 retail sales by licensed medical cannabis dispensaries reached $238,039,128.10, and total retail sales since November 2015 by licensed medical cannabis dispensaries reached $2,201,604,035.58. May: $24,413,018.67
We’re one week away from the 2024 Illinois Cannabis Convention , and Illinois News Joint invites vendors and attendees to stop by Booth 221 for some free swag and learn about the array of services we provide for the Illinois cannabis industry, including News Joint Events, News Joint Printing, News Joint Bar Service, News Joint Consulting, and more.
Licensed medical cannabis dispensaries served 54,883 unique patients, who purchased 1,151,194 grams of dry cannabis. Monthly Totals for 2024: January: $24,338,551.30 2024 Yearly Totals: $285,059,601.92 February 2025 medical cannabis sales included $9,625,137.04 in dry flower sales and $10,123,062.80 February: $19,748,199.87
As we move forward into 2024 and beyond, the sector offers diverse paths beyond direct patient care. In this article, we explore seven compelling non-clinical healthcare jobs poised to thrive in 2024 and beyond. Adverse drug events (ADEs) affect approximately 7 per 100 hospitalized patients.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content